Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.70
Share price
-0.57%
Change (1 day)
12.18%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ0.93 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are ยฃ0.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ1.02 B-24.2%
2023-12-31ยฃ1.35 B-30.79%
2022-12-31ยฃ1.95 B-8.47%
2021-12-31ยฃ2.13 B-22.2%
2020-12-31ยฃ2.74 B0.81%
2019-12-31ยฃ2.72 B1243.68%
2018-12-31ยฃ0.20 B-16.64%
2017-12-31ยฃ0.24 B-12.01%
2016-12-31ยฃ0.27 B383.87%
2015-12-31ยฃ57.19 M13.81%
2014-12-31ยฃ50.25 M-50.08%
2013-12-31ยฃ0.10 B5.24%
2012-12-31ยฃ95.65 M168.25%
2011-12-31ยฃ35.65 M-8.95%
2010-12-31ยฃ39.16 M27%
2009-12-31ยฃ30.83 M-6.29%
2008-12-31ยฃ32.9 M-10.63%
2007-12-31ยฃ36.82 M-5.93%
2006-12-31ยฃ39.14 M178.94%
2005-12-31ยฃ14.03 M278.56%
2004-12-31ยฃ3.7 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
ยฃ51.36 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ85.16 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ49.52 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ102.38 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
ยฃ91.89 M-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ24.69 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.45 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ45.96 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ58.23 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA